Clinical Trial Update: Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) [Phase 3]

View source ↗

Summary

This entry notes a Phase 3 trial comparing Doxorubicin by infusion to chemoembolization for advanced unresectable hepatocellular carcinoma (liver cancer); the c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: University Hospital Birmingham | Conditions: Liver Cancer | Phase 3 | Status: UNKNOWN